{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:46:58Z","timestamp":1762177618562},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To describe the incidence of endophthalmitis and the treatment outcomes of acute bacterial endophthalmitis following intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections in a Brazilian hospital. The analysis was based on the timing of infection after intravitreal injection, culture results, visual acuity, and the presence of epiretinal membrane after a 1-year follow-up period, spanning nine years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective case series, conducted over a 9-year period, aimed to evaluate the treatment outcomes of acute endophthalmitis following intravitreal Bevacizumab injections. The inclusion criteria involved a chart review of 25 patients who presented clinical signs of acute endophthalmitis out of a total of 12,441 injections administered between January 2011 and December 2019. Negative culture results of vitreous samples or incomplete data were excluded. Ultimately, 23 patients were enrolled in the study. Eight patients were treated with intravitreal antibiotic injections (IVAI) using vancomycin 1.0\u00a0mg\/0.05mL and ceftazidime 2.25\u00a0mg\/0.05mL, while 15 patients underwent pars plana vitrectomy (PPV) followed by intravitreal antibiotic injections at the end of surgery (IVAIES). The main outcome measures were the efficacy of controlling the infection with IVAI as a standalone therapy compared to early PPV followed by IVAIES. Data collected included pre-infection and one-year post-treatment best corrected visual acuity (BCVA), optical coherence tomography (OCT) abnormalities, and enucleation\/evisceration rates. To compare groups, Mann-Whitney and ANOVA tests were employed for statistical analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The incidence rate of bacterial endophthalmitis was 0.185% (1\/541 anti-VEGF injections), with the highest infection rates observed in 2014 and 2017. Patients presented clinical symptoms between 2 and 7 days after injection. The most common isolated organisms were coagulase-negative <jats:italic>Staphylococci<\/jats:italic> and <jats:italic>Streptococci spp<\/jats:italic>. Treatment outcomes showed that both IVAI and PPV\u2009+\u2009IVAIES effectively controlled the infection and prevented globe atrophy. After one year, the PPV group with BCVA better than Light Perception had a significantly better BCVA compared to the IVAI group (p 0.003). However, PPV group had higher incidence of epiretinal membranes formation compared to the IVAI group. (P 0.035)<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Anti-VEGF injections carry a risk of developing acute bacterial endophthalmitis. Isolated antibiotic therapy could be an effective treatment to control the infection, but performing PPV\u2009+\u2009IVAIES as a primary treatment showed promising results in terms of improving BCVA after one year, despite a higher rate of epiretinal membrane formation. Further studies are needed to confirm these findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40942-023-00490-9","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T10:02:43Z","timestamp":1695722563000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series"],"prefix":"10.1186","volume":"9","author":[{"given":"Vinicius Campos","family":"Bergamo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Filipe","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilva Simeren Bueno De","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cec\u00edlia Zorat","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Luiza","family":"H\u00f6fling-Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maur\u00edcio","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"490_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3341\/kjo.2017.0036","volume":"31","author":"SJ Sheu","year":"2017","unstructured":"Sheu SJ, Endophthalmitis. Korean J Ophthalmol. 2017;31:283\u20139. https:\/\/doi.org\/10.3341\/kjo.2017.0036","journal-title":"Korean J Ophthalmol"},{"key":"490_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.sjopt.2012.02.011","volume":"26","author":"JR Safneck","year":"2012","unstructured":"Safneck JR, Endophthalmitis. A review of recent trends. Saudi J Ophthalmol. 2012;26:181\u20139. https:\/\/doi.org\/10.1016\/j.sjopt.2012.02.011","journal-title":"Saudi J Ophthalmol"},{"key":"490_CR3","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","volume":"113","author":"Results of the Endophthalmitis Vitrectomy Study","year":"1995","unstructured":"Results of the Endophthalmitis Vitrectomy Study. A Randomized Trial of Immediate Vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthal. 1995;113:1479\u201396. https:\/\/doi.org\/10.1001\/archopht.1995.01100120009001","journal-title":"Arch Ophthal"},{"key":"490_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/opth.s9206","volume":"4","author":"G Javey","year":"2010","unstructured":"Javey G, Schwartz SG, Moshfeghi AA, Asrani S, Flynn HW Jr. Methicillin-resistant Staphylococcus epidermidis isolation from the vitrectomy specimen four hours after initial treatment with vancomycin and ceftazidime. Clin Ophthalmol. 2010;4:101\u20134. https:\/\/doi.org\/10.2147\/opth.s9206","journal-title":"Clin Ophthalmol"},{"key":"490_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2147\/OPTH.S77067","volume":"9","author":"DK Sigford","year":"2015","unstructured":"Sigford DK, Reddy S, Mollineaux C, Schaal S. Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis. Clin Ophthalmol. 2015;9:773\u201381. https:\/\/doi.org\/10.2147\/OPTH.S77067","journal-title":"Clin Ophthalmol"},{"key":"490_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/OPTH.S76406","volume":"9","author":"K Vaziri","year":"2015","unstructured":"Vaziri K, Schwartz SG, Kishor K, Flynn HW Jr. Endophthalmitis: state of the art. Clin Ophthalmol. 2015;9:95\u2013108. https:\/\/doi.org\/10.2147\/OPTH.S76406","journal-title":"Clin Ophthalmol"},{"key":"490_CR7","doi-asserted-by":"crossref","unstructured":"Forster RK. Endophthalmitis Study. Arch Ophthal. 1995;113.","DOI":"10.1001\/archopht.1995.01100120085015"},{"key":"490_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00006982-200410001-00002","volume":"24","author":"LP Aiello","year":"2004","unstructured":"Aiello LP, Brucker AJ, Chang S, Cunningham ET, D\u2019Amico DJ, Flynn HW, et al. Evolving guidelines for intravitreous injections. Retina. 2004;24:3\u201319. https:\/\/doi.org\/10.1097\/00006982-200410001-00002","journal-title":"Retina"},{"key":"490_CR9","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/s0161-6420(02)01179-x","volume":"109","author":"GY Fujii","year":"2002","unstructured":"Fujii GY, De Juan E Jr, Humayun MS, Pieramici DJ, Chang TS, Awh C, et al. A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology. 2002;109:1807\u201312. https:\/\/doi.org\/10.1016\/s0161-6420(02)01179-x. discussion 1813.","journal-title":"Ophthalmology"},{"key":"490_CR10","doi-asserted-by":"publisher","unstructured":"Lau PE, Jenkins KS, Layton CJ. Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections. J Ophthalmol. 2018;2018. https:\/\/doi.org\/10.1155\/2018\/8567912","DOI":"10.1155\/2018\/8567912"},{"key":"490_CR11","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1111\/aos.13623","volume":"96","author":"A Grzybowski","year":"2018","unstructured":"Grzybowski A, Turczynowska M, Kuhn F. The treatment of postoperative endophthalmitis: should we still follow the endophthalmitis vitrectomy study more than two decades after its publication? Acta Ophthalmol. 2018;96:e651\u20134. https:\/\/doi.org\/10.1111\/aos.13623","journal-title":"Acta Ophthalmol"},{"key":"490_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/bjophthalmol-2015-307081","volume":"100","author":"JM Smith","year":"2016","unstructured":"Smith JM, Mathias MT, Oliver SC, Mandava N, Olson JL, Quiroz-Mercado H, et al. The influence of needle gauge and infection source on vitreous aspirate cultures. Br J Ophthalmol. 2016;100:453\u20135. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307081","journal-title":"Br J Ophthalmol"},{"key":"490_CR13","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00417-012-1926-7","volume":"250","author":"AM Almanjoumi","year":"2012","unstructured":"Almanjoumi AM, Combey A, Romanet JP, Chiquet C. 23-Gauge Transconjunctival Sutureless Vitrectomy in Treatment of Post-Operative Endophthalmitis. Graefes Arch Clin Exp Ophthalmol. 2012;250:1367\u201371. https:\/\/doi.org\/10.1007\/s00417-012-1926-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"490_CR14","doi-asserted-by":"publisher","unstructured":"Kuhn F, Gini G. Ten years after... are findings of the Endophthalmitis Vitrectomy Study still relevant today? Graefes Arch Clin Exp Ophthalmol. 2005;243: 1197\u20131199. https:\/\/doi.org\/10.1007\/s00417-005-0082-8","DOI":"10.1007\/s00417-005-0082-8"},{"key":"490_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00417-011-1851-1","volume":"250","author":"C Irigoyen","year":"2012","unstructured":"Irigoyen C, Ziahosseini K, Morphis G, Stappler T, Heimann H. Endophthalmitis following intravitreal injections. Graefes Arch Clin Exp Ophthalmol. 2012;250:499\u2013505. https:\/\/doi.org\/10.1007\/s00417-011-1851-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"490_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.survophthal.2018.02.003","volume":"63","author":"B Clarke","year":"2018","unstructured":"Clarke B, Williamson TH, Gini G, Gupta B. Management of bacterial postoperative endophthalmitis and the role of vitrectomy. Surv Ophthalmol. 2018;63:677\u201393. https:\/\/doi.org\/10.1016\/j.survophthal.2018.02.003","journal-title":"Surv Ophthalmol"},{"key":"490_CR17","doi-asserted-by":"publisher","first-page":"18088","DOI":"10.1038\/s41598-017-18412-9","volume":"7","author":"MF Bande","year":"2017","unstructured":"Bande MF, Mansilla R, Pata MP, Fern\u00e1ndez M, Blanco-Teijeiro MJ, Pi\u00f1eiro A, et al. Intravitreal injections of anti-VEGF agents and antibiotic prophylaxis for endophthalmitis: a systematic review and meta-analysis. Sci Rep. 2017;7:18088. https:\/\/doi.org\/10.1038\/s41598-017-18412-9","journal-title":"Sci Rep"},{"key":"490_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3928\/23258160-20140306-08","volume":"45","author":"B John","year":"2014","unstructured":"John B, Fileta MD, Ingrid U, Scott MDMPH, Harry W, Flynn MD. Meta-analysis of infectious Endophthalmitis after Intravitreal Injection of Anti-Vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina. 2014;45:143\u20139.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"490_CR19","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.3201\/eid2101.141040","volume":"21","author":"LS Edison","year":"2015","unstructured":"Edison LS, Dishman HO, Tobin-D\u2019Angelo MJ, Allen CR, Guh AY, Drenzek CL. Endophthalmitis Outbreak Associated with Repackaged Bevacizumab. Emerg Infect Dis. 2015;21:2013\u20135.","journal-title":"Emerg Infect Dis"},{"key":"490_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.oret.2016.11.008","volume":"1","author":"S Singh","year":"2017","unstructured":"Singh S, Appanraj R, Saravanan V, Manayath GJ, Narendran V, Sharma T, et al. Endophthalmitis after Intravitreal Bevacizumab Injection using pooling or aliquoting technique. Ophthalmol Retina. 2017;1:259\u201360. https:\/\/doi.org\/10.1016\/j.oret.2016.11.008","journal-title":"Ophthalmol Retina"},{"key":"490_CR21","doi-asserted-by":"publisher","unstructured":"Mehraban Far P, Yeung C, Laghaei Farimani S, Qian P, Zhang JQ, Kertes A et al. PJ,. Tap and Inject versus Pars Plana vitrectomy for post-procedural endophthalmitis: A Meta-analysis. Retina. 2021;Publish Ah. https:\/\/doi.org\/10.1097\/IAE.0000000000003203","DOI":"10.1097\/IAE.0000000000003203"},{"key":"490_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/ceo.13914","volume":"49","author":"AT Fung","year":"2021","unstructured":"Fung AT, Galvin J, Tran T. Epiretinal membrane: a review. Clin Exp Ophthalmol. 2021;49:289\u2013308. https:\/\/doi.org\/10.1111\/ceo.13914","journal-title":"Clin Exp Ophthalmol"},{"key":"490_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00347-014-3048-6","volume":"112","author":"J Sebag","year":"2015","unstructured":"Sebag J. Die vitreoretinale Grenzfl\u00e4che und ihre Rolle in der Pathogenese vitreomakul\u00e4rer Erkrankungen. Ophthalmologe. 2015;112:10\u20139. https:\/\/doi.org\/10.1007\/s00347-014-3048-6","journal-title":"Ophthalmologe"},{"key":"490_CR24","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/eye.2008.36","volume":"22","author":"DRJ Snead","year":"2008","unstructured":"Snead DRJ, James S, Snead MP. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation. Eye. 2008;22:1310\u20137. https:\/\/doi.org\/10.1038\/eye.2008.36","journal-title":"Eye"},{"key":"490_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10792-012-9702-6","volume":"33","author":"EY Pinarci","year":"2013","unstructured":"Pinarci EY, Yesilirmak N, Bayar SA, Sizmaz S, Akkoyun I, Yilmaz G. The results of pars plana vitrectomy and silicone oil tamponade for endophthalmitis after intravitreal injections. Int Ophthalmol. 2013;33:361\u20135. https:\/\/doi.org\/10.1007\/s10792-012-9702-6","journal-title":"Int Ophthalmol"},{"key":"490_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003759","author":"AC Sen","year":"2023","unstructured":"Sen AC, Mehta SM, Sule A, More AV, Shetty SB, Singh J, et al. Immediate Vitrectomy vs tap and inject in eyes with Acute Post-cataract endophthalmitis and visual acuity \u2265 HM: a Randomized Clinical Trial. Retina. 2023. https:\/\/doi.org\/10.1097\/IAE.0000000000003759","journal-title":"Retina"},{"key":"490_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000518236","volume":"245","author":"M Finkelstein","year":"2022","unstructured":"Finkelstein M, Katz G, Zur D, Rubowitz A, Moisseiev E. The effect of syringe-filling technique on the risk for Endophthalmitis after Intravitreal Injection of Anti-VEGF Agents. Ophthalmologica. 2022;245:34\u201340. https:\/\/doi.org\/10.1159\/000518236","journal-title":"Ophthalmologica"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-023-00490-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-023-00490-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-023-00490-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T22:37:55Z","timestamp":1700519875000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-023-00490-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["490"],"URL":"https:\/\/doi.org\/10.1186\/s40942-023-00490-9","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"22 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The university\u2019s Ethics Committee approved the study (number 0060\/2018), and informed consent was waived due to its retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}